Company / Accounts Receivable
HARVARD BIOSCIENCE INC Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$16.0M
FY2025
5-year range
$14.9M / $21.8M
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable returned to growth in FY2025 after 3 years of decline, reaching $16M.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of -5.0%.
Remained stable around $16M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.0%, indicating a declining trend.
- In FY2025, accounts receivable increased 7.9% year-over-year.
- Peak accounts receivable was recorded in FY2021.
- Lowest accounts receivable in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.0M | +7.9% |
| FY2024 | $14.9M | -7.7% |
| FY2023 | $16.1M | -3.6% |
| FY2022 | $16.7M | -23.5% |
| FY2021 | $21.8M | +5.5% |
| FY2020 | $20.7M | +0.0% |
| FY2019 | $20.7M | -3.5% |
| FY2018 | $21.5M | +32.2% |
| FY2017 | $16.2M | +3.1% |
| FY2016 | $15.7M | -10.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026